Charles Schwab’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3M Sell
808,436
-26,359
-3% -$731K ﹤0.01% 1769
2025
Q4
$23.1M Sell
834,795
-6,415
-0.8% -$164K ﹤0.01% 1659
2025
Q3
$20.4M Buy
841,210
+66,359
+9% +$1.32M ﹤0.01% 1723
2025
Q2
$13.2M Sell
774,851
-1,594
-0.2% -$27.8K ﹤0.01% 1883
2025
Q1
$15.2M Buy
776,445
+127,500
+20% +$3.34M ﹤0.01% 1763
2024
Q4
$16.1M Buy
648,945
+19,453
+3% +$496K ﹤0.01% 1806
2024
Q3
$15.4M Buy
629,492
+36,226
+6% +$936K ﹤0.01% 1834
2024
Q2
$13.9M Buy
593,266
+13,994
+2% +$344K ﹤0.01% 1876
2024
Q1
$19.1M Buy
579,272
+8,036
+1% +$250K ﹤0.01% 1638
2023
Q4
$15.5M Buy
571,236
+29,826
+6% +$741K ﹤0.01% 1744
2023
Q3
$13M Buy
541,410
+39,990
+8% +$1.07M ﹤0.01% 1772
2023
Q2
$16M Buy
501,420
+37,806
+8% +$1.23M ﹤0.01% 1645
2023
Q1
$14.2M Buy
463,614
+2,460
+0.5% +$97.1K ﹤0.01% 1702
2022
Q4
$18M Buy
461,154
+9,247
+2% +$414K 0.01% 1514
2022
Q3
$21.5M Buy
451,907
+54,458
+14% +$3.11M 0.01% 1313
2022
Q2
$15.4M Buy
397,449
+26,533
+7% +$1.05M 0.01% 1584
2022
Q1
$21.3M Buy
370,916
+23,092
+7% +$1.51M 0.01% 1493
2021
Q4
$27.7M Buy
347,824
+14,304
+4% +$1.22M 0.01% 1327
2021
Q3
$29M Buy
333,520
+82,078
+33% +$8.25M 0.01% 1256
2021
Q2
$32.4M Buy
251,442
+31,750
+14% +$2.53M 0.01% 1193
2021
Q1
$17.6M Buy
219,692
+16,010
+8% +$1.52M 0.01% 1627
2020
Q4
$16.6M Buy
203,682
+32,171
+19% +$1.58M 0.01% 1531
2020
Q3
$4.22M Buy
171,511
+88,909
+108% +$2.21M ﹤0.01% 2148
2020
Q2
$2.31M Buy
82,602
+56,597
+218% +$1.22M ﹤0.01% 2374
2020
Q1
$469K Buy
+26,005
New +$565K ﹤0.01% 2738

Other funds holding BEAM